Ali Tehrani Zymeworks Inc. (ZYME) insider trading activity

Ali Tehrani is Chief Executive Officer of Zymeworks Inc.. Currently has a direct ownership of 260,325 shares of ZYME, which is worth approximately $3.61 Million. The most recent transaction as insider was on Jul 16, 2021, when has been sold 41,191 shares (Common Shares) at a price of $36.0 per share, resulting in proceeds of $1,482,876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

0% 3M change

0% 12M change

Total Value Held $3.61 Million

Ali Tehrani Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2021	SELL Open market or private sale	$1,482,876 $36.0 p/Share	41,191 Reduced 13.66%	260,325 Common Shares
Jul 16 2021	BUY Exercise of conversion of derivative security	$175,474 $4.26 p/Share	41,191 Added 12.02%	301,516 Common Shares
Jul 15 2021	SELL Open market or private sale	$136,800 $36.0 p/Share	3,800 Reduced 1.44%	260,325 Common Shares
Jul 15 2021	BUY Exercise of conversion of derivative security	$16,226 $4.27 p/Share	3,800 Added 1.42%	264,125 Common Shares
Jul 12 2021	SELL Open market or private sale	$457,604 $36.12 p/Share	12,669 Reduced 4.64%	260,325 Common Shares
Jul 12 2021	BUY Exercise of conversion of derivative security	$54,603 $4.31 p/Share	12,669 Added 4.43%	272,994 Common Shares
Mar 10 2021	SELL Open market or private sale	$153,500 $34.95 p/Share	4,392 Reduced 1.66%	260,325 Common Shares
Mar 10 2021	BUY Exercise of conversion of derivative security	-	7,708 Added 2.83%	264,717 Common Shares

Ali Tehrani

Chief Executive Officer

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYME shares.

Notify only if

Value

Insider Trading

Get notified when an Zymeworks Inc. insider buys or sells ZYME shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zymeworks Inc.

Track Activities on ZYME

Account